Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Bother Control Administrations for 2024: Decide for Your Home - 2Moon rocket and weather are on NASA's side for the first astronaut launch in decades
- 3Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
- 4Moving Wedding Objections for Paramount Functions
- 5Kuwait is softening stance on Israel, dissident tells ‘Post’ after viral UN speech
- Trump signs a law returning whole milk to school lunches
- Step by step instructions to Protect Your Speculations with Cd Rates
- The most effective method to Decide the Best Auto Crash Attorney for Your Lawful Necessities
- Does physics say that free will doesn't exist?
- Step by step instructions to Safeguard Your Teeth During Sports Exercises
- Most loved Road Food: Which One Prevails upon You?
- Brazil's Bolsonaro to continue his sentence at home because of poor health
- Protest inspired by 'Gen Z' movement draws few young people in Mexico and many government critics
- Ifo: Job cuts in Germany slowing but not enough for a turnaround
